Pioneering
Regenerative Medicine
The First cGMP-Certified Stem Cell Manufacturing Facility Established by a Pharmaceutical Company in Indonesia.
Why Choose Us?
Regenic is steadfast in its commitment to quality, safety and ethical standards. As Indonesia's first cGMP-certified stem cell manufacturing facility established as a pharmaceutical company, we strictly comply to regulatory requirements with benchmarking to international best practices. Equipped with state-of-the-art technology and staffed by highly skilled experts, our facility ensures the highest standard of production. We are proud to hold multiple certifications and licenses, including:
cGMP Certificate from Indonesian FDA (BPOM)
Strictly follows current Good Manufacturing Practices (cGMP) standard of Indonesian FDA (BPOM) to ensure product quality and safety.
Operating License from Indonesian Ministry of Health
Authorized by the Indonesian Ministry of Health with an official operating license for stem cell and secretome manufacturing
Experienced Team Members
Comprised of a highly experienced team with extensive industry knowledge.
Transforming Lives Through Cellular Innovation
As a pioneer in regenerative medicine, Regenic proudly stands as Indonesia's first cGMP-certified stem cell manufacturing facility. We are dedicated to harnessing the potential of cellular therapy to develop innovative solutions for diverse health challenges. Guided by our unwavering commitment to quality, safety, and ethical practices, we are driven by the transformative power of cell therapy and honored to lead advancements in this groundbreaking field.
Stem cells are the body's 'parent cells,'forming the foundation for organs, tissues, blood, and the immune system. They can develop into various cell types and act as an internal repair system, replenishing damaged or lost cells. Additionally, stem cells secrete bioactive molecules, known as the secretome, which play a key role in cellular communication, healing, and anti-inflammatory effects. This unique ability makes them a promising renewable source for treating conditions like spinal cord injuries, osteoarthritis
News & Events
Potential of Cell Therapy Using Mesenchymal Stem Cells for Parkinson's Disease
23 December 2024
Regenic Writer
Parkinson's disease is a neurodegenerative disease associated with aging. The prevalence of Parkinson's is about 2% in patients over the age of 65. Parkinson's disease is a complex disorder that is difficult to diagnose clinically, especially in its early stages. Parkinson's generally occurs in the substantia nigra (SN) striatum pathway with degeneration of dopaminergic
Let's understand the differences between Stem Cells, Secretome, and Exosomes.
23 December 2024
Regenic Writer
In recent years, medical science has achieved various remarkable innovations, especially in the fields of cell regeneration and treatment. Among the terms frequently discussed in this context are stem cells, secretome, and exosomes
Basic Training "Stem Cell, Secretome & Exosome for Regenerative Medicine" Series 5
23 December 2024
Regenic Writer
June 25, 2024. Regenic organized an event titled "Stem Cells, Secretome & Exosomes for Regenerative Medicine: From High-Quality Product Manufacturing at GMP-Certified Facilities to Clinical Applications." The event featured three highly